Abstract
Renal cell cancer is one of the tenth most frequent tumor-dependent causes of death worldwide. In localized stages surgical therapy is the only curative option for the patient. If a renal cell carcinoma is diagnosed in late, i.e. advanced/metastasized stages a drug therapy with targeted agents following tumor burden surgery is nowadays the best option to increase patients progression-free survival. Whenever possible, a partial resection should be perform on regard to decrease rates of longtime renal failure.
| Translated title of the contribution | Renal cell cancer. From symptoms to therapy |
|---|---|
| Original language | German |
| Journal | Chirurgische Praxis |
| Volume | 76 |
| Issue number | 1 |
| Pages (from-to) | 123-129 |
| Number of pages | 7 |
| ISSN | 0009-4846 |
| Publication status | Published - 02.2013 |
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)
